
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Chia‐Chen Liu, Melissa E. Murray, Xia Li, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 613
Open Access | Times Cited: 66
Chia‐Chen Liu, Melissa E. Murray, Xia Li, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 613
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 335
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 335
ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias
Yuka A. Martens, Na Zhao, Chia‐Chen Liu, et al.
Neuron (2022) Vol. 110, Iss. 8, pp. 1304-1317
Open Access | Times Cited: 213
Yuka A. Martens, Na Zhao, Chia‐Chen Liu, et al.
Neuron (2022) Vol. 110, Iss. 8, pp. 1304-1317
Open Access | Times Cited: 213
Solving neurodegeneration: common mechanisms and strategies for new treatments
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 193
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 193
The complex genetic architecture of Alzheimer's disease: novel insights and future directions
Shea J. Andrews, Alan E. Renton, Brian Fulton‐Howard, et al.
EBioMedicine (2023) Vol. 90, pp. 104511-104511
Open Access | Times Cited: 191
Shea J. Andrews, Alan E. Renton, Brian Fulton‐Howard, et al.
EBioMedicine (2023) Vol. 90, pp. 104511-104511
Open Access | Times Cited: 191
Emerging roles of innate and adaptive immunity in Alzheimer’s disease
Xiaoying Chen, David M. Holtzman
Immunity (2022) Vol. 55, Iss. 12, pp. 2236-2254
Open Access | Times Cited: 166
Xiaoying Chen, David M. Holtzman
Immunity (2022) Vol. 55, Iss. 12, pp. 2236-2254
Open Access | Times Cited: 166
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease
Samira Parhizkar, David M. Holtzman
Seminars in Immunology (2022) Vol. 59, pp. 101594-101594
Open Access | Times Cited: 132
Samira Parhizkar, David M. Holtzman
Seminars in Immunology (2022) Vol. 59, pp. 101594-101594
Open Access | Times Cited: 132
Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function
Chia‐Chen Liu, Jing Zhao, Yuan Fu, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 8, pp. 1020-1033
Open Access | Times Cited: 101
Chia‐Chen Liu, Jing Zhao, Yuan Fu, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 8, pp. 1020-1033
Open Access | Times Cited: 101
Apolipoprotein E in lipid metabolism and neurodegenerative disease
Linda Yang, Zachary M. March, Roxan A. Stephenson, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 8, pp. 430-445
Open Access | Times Cited: 75
Linda Yang, Zachary M. March, Roxan A. Stephenson, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 8, pp. 430-445
Open Access | Times Cited: 75
Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer’s disease
Chia‐Chen Liu, Na Wang, Yuanxin Chen, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1854-1866
Closed Access | Times Cited: 64
Chia‐Chen Liu, Na Wang, Yuanxin Chen, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1854-1866
Closed Access | Times Cited: 64
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread
Yun Chen, Sihui Song, Samira Parhizkar, et al.
Cell (2023) Vol. 187, Iss. 2, pp. 428-445.e20
Open Access | Times Cited: 50
Yun Chen, Sihui Song, Samira Parhizkar, et al.
Cell (2023) Vol. 187, Iss. 2, pp. 428-445.e20
Open Access | Times Cited: 50
Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
Jean‐Charles Lambert, Alfredo Ramı́rez, Benjamin Grenier‐Boley, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2716-2727
Open Access | Times Cited: 49
Jean‐Charles Lambert, Alfredo Ramı́rez, Benjamin Grenier‐Boley, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2716-2727
Open Access | Times Cited: 49
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation
Maxine Nelson, Peng Liu, Ayushi Agrawal, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 12, pp. 2104-2121
Open Access | Times Cited: 47
Maxine Nelson, Peng Liu, Ayushi Agrawal, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 12, pp. 2104-2121
Open Access | Times Cited: 47
Multifaceted roles of APOE in Alzheimer disease
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 35
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 35
ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer’s disease
Guiqin Chen, Mengmeng Wang, Zhentao Zhang, et al.
Neuron (2025) Vol. 113, Iss. 5, pp. 719-736.e5
Closed Access | Times Cited: 2
Guiqin Chen, Mengmeng Wang, Zhentao Zhang, et al.
Neuron (2025) Vol. 113, Iss. 5, pp. 719-736.e5
Closed Access | Times Cited: 2
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease
Yann Le Guen, Michaël E. Belloy, Benjamin Grenier‐Boley, et al.
JAMA Neurology (2022) Vol. 79, Iss. 7, pp. 652-652
Open Access | Times Cited: 56
Yann Le Guen, Michaël E. Belloy, Benjamin Grenier‐Boley, et al.
JAMA Neurology (2022) Vol. 79, Iss. 7, pp. 652-652
Open Access | Times Cited: 56
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Carmen Romero‐Molina, Francesca Garretti, Shea J. Andrews, et al.
Neuron (2022) Vol. 110, Iss. 21, pp. 3513-3533
Open Access | Times Cited: 56
Carmen Romero‐Molina, Francesca Garretti, Shea J. Andrews, et al.
Neuron (2022) Vol. 110, Iss. 21, pp. 3513-3533
Open Access | Times Cited: 56
Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
Na Wang, Minghui Wang, Suren Jeevaratnam, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Na Wang, Minghui Wang, Suren Jeevaratnam, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 47
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2044-2044
Open Access | Times Cited: 23
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2044-2044
Open Access | Times Cited: 23
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
Courtney M. Kloske, Michaël E. Belloy, Elizabeth Blue, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6590-6605
Open Access | Times Cited: 10
Courtney M. Kloske, Michaël E. Belloy, Elizabeth Blue, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6590-6605
Open Access | Times Cited: 10
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Sadequl Islam, Arshad Ali Noorani, Yang Sun, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access | Times Cited: 1
Sadequl Islam, Arshad Ali Noorani, Yang Sun, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access | Times Cited: 1
The impact of rare genetic variants on Alzheimer disease
Lara De Deyn, Kristel Sleegers
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 1
Lara De Deyn, Kristel Sleegers
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 1
Lipoproteins in the Central Nervous System: From Biology to Pathobiology
Ana‐Caroline Raulin, Yuka A. Martens, Guojun Bu
Annual Review of Biochemistry (2022) Vol. 91, Iss. 1, pp. 731-759
Open Access | Times Cited: 38
Ana‐Caroline Raulin, Yuka A. Martens, Guojun Bu
Annual Review of Biochemistry (2022) Vol. 91, Iss. 1, pp. 731-759
Open Access | Times Cited: 38
Genetics of Alzheimer’s disease: an East Asian perspective
Akinori Miyashita, Masataka Kikuchi, Norikazu Hara, et al.
Journal of Human Genetics (2022) Vol. 68, Iss. 3, pp. 115-124
Open Access | Times Cited: 29
Akinori Miyashita, Masataka Kikuchi, Norikazu Hara, et al.
Journal of Human Genetics (2022) Vol. 68, Iss. 3, pp. 115-124
Open Access | Times Cited: 29
APOE Christchurch‐mimetic therapeutic antibody reduces APOE‐mediated toxicity and tau phosphorylation
Claudia Mariño, Paula Perez‐Corredor, Michael O’Hare, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 819-836
Open Access | Times Cited: 22
Claudia Mariño, Paula Perez‐Corredor, Michael O’Hare, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 819-836
Open Access | Times Cited: 22